A detailed history of Victory Capital Management Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Victory Capital Management Inc holds 144,034 shares of JAZZ stock, worth $15.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
144,034
Previous 136,589 5.45%
Holding current value
$15.4 Million
Previous $16.8 Million 3.24%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$115.19 - $132.77 $857,589 - $988,472
7,445 Added 5.45%
144,034 $17.3 Million
Q4 2023

Feb 05, 2024

BUY
$114.26 - $136.0 $641,455 - $763,504
5,614 Added 4.29%
136,589 $16.8 Million
Q3 2023

Nov 06, 2023

SELL
$122.0 - $145.31 $708,942 - $844,396
-5,811 Reduced 4.25%
130,975 $17 Million
Q2 2023

Jul 27, 2023

BUY
$122.5 - $147.16 $490,980 - $589,817
4,008 Added 3.02%
136,786 $17 Million
Q1 2023

May 02, 2023

SELL
$133.98 - $160.47 $55.5 Million - $66.5 Million
-414,181 Reduced 75.72%
132,778 $19.4 Million
Q4 2022

Feb 10, 2023

BUY
$129.72 - $159.85 $20,625 - $25,416
159 Added 0.03%
546,959 $87.1 Million
Q4 2022

Feb 09, 2023

SELL
$129.72 - $159.85 $33.7 Million - $41.5 Million
-259,899 Reduced 32.22%
546,800 $87.1 Million
Q3 2022

Nov 02, 2022

BUY
$126.59 - $161.18 $6.35 Million - $8.08 Million
50,153 Added 6.63%
806,699 $108 Million
Q2 2022

Aug 01, 2022

BUY
$141.59 - $168.66 $15.8 Million - $18.8 Million
111,605 Added 17.3%
756,546 $118 Million
Q1 2022

May 04, 2022

SELL
$129.64 - $160.7 $22 Million - $27.2 Million
-169,525 Reduced 20.81%
644,941 $101 Million
Q4 2021

Feb 07, 2022

BUY
$119.87 - $145.67 $10.2 Million - $12.4 Million
84,842 Added 11.63%
814,466 $104 Million
Q3 2021

Nov 02, 2021

SELL
$128.64 - $184.79 $267,957 - $384,917
-2,083 Reduced 0.28%
729,624 $95 Million
Q2 2021

Aug 03, 2021

BUY
$160.2 - $186.42 $103 Million - $120 Million
641,921 Added 714.95%
731,707 $130 Million
Q1 2021

May 04, 2021

BUY
$150.19 - $173.5 $255,773 - $295,470
1,703 Added 1.93%
89,786 $14.8 Million
Q4 2020

Feb 01, 2021

BUY
$140.71 - $165.05 $1.6 Million - $1.88 Million
11,373 Added 14.83%
88,083 $14.5 Million
Q3 2020

Nov 09, 2020

BUY
$105.46 - $144.13 $3.75 Million - $5.12 Million
35,516 Added 86.22%
76,710 $10.9 Million
Q2 2020

Aug 07, 2020

BUY
$95.68 - $121.88 $480,504 - $612,081
5,022 Added 13.88%
41,194 $4.55 Million
Q1 2020

May 04, 2020

SELL
$87.74 - $152.74 $5.19 Million - $9.04 Million
-59,164 Reduced 62.06%
36,172 $3.61 Million
Q4 2019

Feb 06, 2020

SELL
$117.65 - $153.73 $3.08 Million - $4.02 Million
-26,152 Reduced 21.53%
95,336 $14.2 Million
Q4 2019

Feb 04, 2020

BUY
$117.65 - $153.73 $1.24 Million - $1.62 Million
10,567 Added 9.53%
121,488 $17.4 Million
Q3 2019

Nov 12, 2019

BUY
$125.18 - $143.24 $782,500 - $895,393
6,251 Added 5.97%
110,921 $14.2 Million
Q2 2019

Aug 15, 2019

BUY
$125.55 - $144.48 $10.9 Million - $12.5 Million
86,606 Added 479.44%
104,670 $14.9 Million
Q1 2019

May 03, 2019

SELL
$121.81 - $142.95 $549,606 - $644,990
-4,512 Reduced 19.99%
18,064 $2.58 Million
Q4 2018

Feb 05, 2019

SELL
$115.94 - $166.74 $20.8 Million - $29.9 Million
-179,424 Reduced 88.82%
22,576 $2.8 Million
Q3 2018

Nov 01, 2018

BUY
$161.01 - $180.57 $30.9 Million - $34.6 Million
191,870 Added 1894.08%
202,000 $34 Million
Q2 2018

Aug 02, 2018

SELL
$146.33 - $183.18 $77,554 - $97,085
-530 Reduced 4.97%
10,130 $1.75 Million
Q1 2018

May 04, 2018

SELL
$135.59 - $157.16 $25,490 - $29,546
-188 Reduced 1.73%
10,660 $1.61 Million
Q4 2017

Feb 01, 2018

BUY
$131.06 - $150.39 $180,862 - $207,538
1,380 Added 14.58%
10,848 $1.46 Million
Q3 2017

Oct 27, 2017

BUY
$142.62 - $155.6 $863,991 - $942,624
6,058 Added 177.65%
9,468 $1.39 Million
Q2 2017

Aug 07, 2017

BUY
N/A
3,410
3,410 $530,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.69B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.